Radiodermatitis Market Is Estimated to Be Worth US$421.5 Mn by the End of 2024
Strong and expanding prevalence of cancer is undeniable, but the failure of humanity to find an adequate therapy for the chronic disease 'without side effects' is another irrefutable reality. For now, cumulative daily doses of radiation therapy are used for cancer treatment, which causes a side-effect called radiodermatitis. Radiodermatitis significantly affects the patient's quality of life by enticing debilitating pain and discomfort and can potentially hinder further treatment regimes.
View full press release